The scientific muscle of Brazil’s health biotechnology

Nature Biotechnology

Volumn 22, Issue 12s, 2004, Pages DC8-DC12

  Ferrer, Marcela ^a   Thorsteinsdóttir, Halla ^b   Quach, Uyen ^b   Singer, Peter A ^b   Daar, Abdallah S ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b at the University of Toronto Wagner is also a faculty member of the Canadian Medical Associations' Physician Management Institute   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICINE; BIOTECHNOLOGY; BRAZIL; COMMERCIAL PHENOMENA; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE COST; HEALTH PROMOTION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; POLICY;

BIOLOGICAL SCIENCES; BIOMEDICAL RESEARCH; BIOTECHNOLOGY; BRAZIL; DEVELOPING COUNTRIES; ENTREPRENEURSHIP; HEALTH CARE SECTOR; HEALTH PROMOTION; PRIVATE SECTOR; PUBLIC POLICY;

EID: 84984778261     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1204supp-DC8     Document Type: Article

References (21)

1. Rebêlo, P. SciDev.Net, 16 June 2004. http://www.scidev.net
2. World Health Organization and International Diabetes Foundation. Diabetes Action Now (WHO, Geneva, Switzerland, 2004). http://www.who.int/diabetes/actionnow/booklet/en/
3. United Nations Conference on Trade and Development. UNCTAD Handbook of Statistics Online (UNCTAD, Geneva, 2003). http://www.unctad.org/Templates/StartPage.asp?intItemID=2068
4. International Business Strategies. The Biotechnology Market in Brazil (International Business Strategies, Los Gatos, CA, USA, 2003).
5. Science-Metrix. Benchmarking of Genomics and Health Biotechnology in Seven Developing Countries, 1991– 2004. Report Prepared for University of Toronto, Joint Centre for Bioethics (Science-Metrix, Quebec, 2004). Data derived from information (subset of Science Citation Index Expanded Database) Prepared by the Institute for Scientific Information (ISI, Philadelphia, PA, USA). © Institute for Scientific Information. All rights reserved.
6. Oda, L.M, Correa Soares, B.E. & Valadares-Inglis, M.C. in Biotechnology in the Developing World and Countries in Economic Transition (eds. Tzotzos, G.T. & Skryabin, K.G.) 43–52 (CAB International, Wallingford, UK, 2000).
7. http://www.inpi.gov.br
8. http://www.anvisa.gov.br
9. Bernardes Marques, M. Int. J. Biotechnol. 5, 38–46 (2004).
10. Massarani, L. SciDev.Net, 13 October 2004. http://www.scidev.net
11. de Oiveira, W. SciDev.Net, 12 November 2003. http://www.scidev.net
12. Coura, J.R. Mem. Inst. Oswaldo Cruz 95, 9–16 (2000).
13. http://aeg.lbi.ic.unicamp.br/xf/
14. UK Trade and Investment. Biotechnology and Pharmaceutical Market in Brazil. http://www.uktradeinvest.gov.uk/biotechnology/brazil/profile/overview.shtml (2003).
15. Mani, S. Government, Innovation and Technology Policy: An International Comparative Analysis (Edward Elgar, Cheltenham, 2002).
16. http://www.adunicamp.org.br/noticias/universidade/leideinova%E7%E3o.pdf
17. http://www.forbes.com/technology/ebusiness/feeds/ap/2004/08/31/ap1525328.html
18. Cruvinel, T. A lei da inovação. Panorama Político O Globo, July 3, 2004.
19. Mantell, K. SciDev.Net. 28 February 2002. http://www.scidev.net
20. Simpson, A.J. et al. Nature 406, 151–157 (2000).
21. http://www.wipo.int/sme/en/case_studies/fk_biotec.htm